Voyager Therapeutics is trading 5.23% down now at $3.35, after no clear company-specific announcement was identified for August 31, 2026.
- The investor-relations page lists the latest event as an August 21 investor presentation; available coverage shows no significant new company news.
- Broader markets are lower amid geopolitical risk, rising oil prices, and hawkish Federal Reserve expectations.
- The overall decline is moderate and does not clearly explain the full move.